AJI MATHEW: Open Payments
NPI 1538713599 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 43 payments from 13 companies in 2025. Trend: 2023 $572 · 2024 $1,002 · 2025 $1,315
Food & beverage: $1,278Education: $37
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 8 | $246 |
| Syndax Pharmaceuticals, Inc. | 6 | $236 |
| Astellas Pharma US Inc | 6 | $196 |
| Novartis Pharmaceuticals Corporation | 5 | $132 |
| GlaxoSmithKline, LLC. | 4 | $103 |
| AstraZeneca Pharmaceuticals LP | 3 | $98 |
| Celgene Corporation | 3 | $73 |
| ABBVIE INC. | 2 | $60 |
| Incyte Corporation | 2 | $58 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
Products named: Vonjo, SCEMBLIX, Cresemba, OJJAARA, CALQUENCE, JAKAFI, REBLOZYL, INQOVI.
Industry payments across TX — which companies pay providers there.
